Product Details
Product Name:
Apimostinel |
CAS No.:
1421866-48-9 |
Supply Ability:
10g |
Release date:
2025/07/16 |
Product Introduction
Bioactivity
Name | Apimostinel |
Description | Apimostinel (NRX-1074; AGN-241660) is a partial agonist of the NMDA receptor. |
In vitro | Apimostinel (NRX-1074) modulates the NMDA receptor similarly to GLYX-13 but includes a synthetic amino acid modification that enhances its potency and oral bioavailability[1]. |
In vivo | In preclinical models, both compounds demonstrate high efficacy in treating various CNS disorders[1]. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Solubility Information | DMSO : 155 mg/mL (307.79 mM), Sonication is recommended.
|
Keywords | AGN241660 | AGN 241660 | NRX 1074 | NRX1074 | Apimostinel |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
-
-
CAS:753498-25-8
$30.00 / 10mg
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |